1855 Capital is excited to welcome our newest portfolio company, Phospholutions, to the 1855 Capital family! We have been working with Phospholutions for a while to put together a great deal and were very excited that Maumee Ventures, the venture capital subsidiary of The Andersons, Inc. (Nasdaq: ANDE), invested alongside 1855 Capital. Phospholutions products help reduce...Read More
1855 Capital is really proud of PLEDGE IT for helping fight childhood cancer. The annual Touchdowns Against Cancer fundraising campaign benefiting St. Jude Children’s Research Hospital uses the PLEDGE IT platform to power their fundraising efforts. Recently, CBS Sports featured PLEDGE IT during the “NFL Today” broadcast and tweeted a video highlighting some of the...Read More
1855 Capital Managing Director Matt Rhodes, and Director of Second Stage Capital at Ben Franklin Technology Partners of Central and Northern PA (and friend of the fund) John Sider, sat down with Penn State President Eric Barron to talk about the impact of the INVENT Penn State initiative and 1855 Capital on communities in Pennsylvania. The interview aired...Read More
